Literature DB >> 8691227

Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry.

B Rzany1, M Mockenhaupt, S Baur, W Schröder, U Stocker, J Mueller, N Holländer, R Bruppacher, E Schöpf.   

Abstract

The severe skin reactions erythema exsudativum multiforme majus (EEM with mucosal involvement, EEMM), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) are difficult to study as they are very rare diseases with an incidence of about two cases per 1 million inhabitants per year. We report on the structure of a registry with the aim of ascertaining all hospitalized cases of EEMM, SJS, and TEN in western Germany and Berlin. The registry is structured as an intensive reporting system, regularly contacting more than 1500 departments including 100% of the burn units (n = 34), departments of pediatrics (n = 241), departments of dermatology (n = 106), and 100% of all internal medicine departments in hospitals with intensive care facilities or with more than 200 beds (n = 1161). With a coverage rate up to 95% based on the number of responding departments between April 1, 1990 and December 31, 1992, from a total of 767 reported cases 353 patients with EEMM, SJS, and TEN were finally included in the registry. Most of these patients were directly reported to the registry; only 2.54% (9 of 353) were primarily registered by the German spontaneous reporting systems. Assuming an average population of 64.5 million for western Germany and Berlin an incidence up to 1.89 per 1 million inhabitants per year could be calculated for SJS and TEN.

Entities:  

Mesh:

Year:  1996        PMID: 8691227     DOI: 10.1016/0895-4356(96)00035-2

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  72 in total

Review 1.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

Review 2.  [Severe cutaneous adverse drug reactions. Clinical features and epidemiology ].

Authors:  M Mockenhaupt
Journal:  Hautarzt       Date:  2005-01       Impact factor: 0.751

3.  [Treatment of toxic epidermal necrolysis. Experience with 9 patients with consideration of intravenous immunoglobulin].

Authors:  P Spornraft-Ragaller; H Theilen; G S Gottschlich; M Ragaller
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

4.  Stevens-Johnson syndrome/toxic epidermal necrolysis: are drug dictionaries correctly informing physicians regarding the risk?

Authors:  Cynthia Haddad; Alexis Sidoroff; Sylvia H Kardaun; Maja Mockenhaupt; Daniel Creamer; Ariane Dunant; Jean-Claude Roujeau
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

5.  Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study.

Authors:  Elisa Martín-Merino; Francisco J de Abajo; Miguel Gil
Journal:  Eur J Clin Pharmacol       Date:  2015-05-05       Impact factor: 2.953

Review 6.  Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes.

Authors:  Manuel Florian Struck; Peter Hilbert; Maja Mockenhaupt; Beate Reichelt; Michael Steen
Journal:  Intensive Care Med       Date:  2009-09-29       Impact factor: 17.440

7.  [Stomatitis, cheilitis and conjunctivitis after a common cold].

Authors:  M Jakob; N Stuhrmann; J Jordan; F Bootz; A Schröck
Journal:  HNO       Date:  2009-09       Impact factor: 1.284

8.  Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening.

Authors:  Suran L Fernando; Andrew J Broadfoot
Journal:  CMAJ       Date:  2009-11-23       Impact factor: 8.262

Review 9.  Adverse drug reactions - examples of detection of rare events using databases.

Authors:  Esther W Chan; Kirin Q L Liu; Celine S L Chui; Chor-Wing Sing; Lisa Y L Wong; Ian C K Wong
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

10.  HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese.

Authors:  F Yang; J Xuan; J Chen; H Zhong; H Luo; P Zhou; X Sun; L He; S Chen; Z Cao; X Luo; Q Xing
Journal:  Pharmacogenomics J       Date:  2015-04-28       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.